Neonatal impact of leukemia inhibitory factor on neurobehavioral development in rats

被引:32
作者
Watanabe, Y
Hashimoto, S
Kakita, A
Takahashi, H
Ko, J
Mizuno, M
Someya, T
Patterson, PH
Nawa, H
机构
[1] Niigata Univ, Brain Res Inst, Div Mol Neurobiol, Niigata 9518585, Japan
[2] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA
[3] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 9518585, Japan
[4] Niigata Univ, Brain Res Inst, Res Branch, Niigata 9518585, Japan
[5] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata 9518585, Japan
关键词
LIF; oncostatin M; CNTF; astrocyte; schizophrenia; autism; PPI;
D O I
10.1016/j.neures.2003.12.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cytokines have been implicated in the etiology or pathology of various psychiatric diseases of developmental origin such as autism and schizophrenia. Leukemia inhibitory factor (LIF) is induced by a variety of brain insults and known to have many influences on mature and immature nervous system. Here, we assessed the neurobehavioral and pathological consequences of peripheral administration of LIF in newborn rats. Subcutaneous LIF injection induced STAT3 phosphorylation in many brain regions and increased glial fibrillary acidic protein (GFAP) immunoreactivity in the neocortex, suggesting that LIF had direct effects in the central nervous system. The LIF-treated rats displayed decreased motor activity during juvenile stages, and developed abnormal prepulse inhibition in the acoustic startle test during and after adolescence. They displayed normal learning ability in active avoidance test, however. Brain neuronal structures and startle responses were grossly normal, except for the cortical astrogliosis during neonatal LIF administration. These results indicate that LIF induction in the periphery of the infant has a significant, but discrete impact on neurobehavioral development. (C) 2003 Elsevier Ireland Ltd and The Japan Neuroscience Society. All rights reserved.
引用
收藏
页码:345 / 353
页数:9
相关论文
共 62 条
[1]   Serum levels of soluble IL-2 receptor α, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration [J].
Akiyama, K .
SCHIZOPHRENIA RESEARCH, 1999, 37 (01) :97-106
[2]   Leukemia inhibitory factor is expressed in astrocytes following cortical brain injury [J].
Banner, LR ;
Moayeri, NN ;
Patterson, PH .
EXPERIMENTAL NEUROLOGY, 1997, 147 (01) :1-9
[3]   Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway [J].
Bonni, A ;
Sun, Y ;
NadalVicens, M ;
Bhatt, A ;
Frank, DA ;
Rozovsky, I ;
Stahl, N ;
Yancopoulos, GD ;
Greenberg, ME .
SCIENCE, 1997, 278 (5337) :477-483
[4]   Prenatal immune challenge disrupts sensorimotor gating in adult rats:: Implications for the etiopathogenesis of schizophrenia [J].
Borrell, J ;
Vela, JM ;
Arévalo-Martin, A ;
Molina-Holgado, E ;
Guaza, C .
NEUROPSYCHOPHARMACOLOGY, 2002, 26 (02) :204-215
[5]  
BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181
[6]   LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival [J].
Butzkueven, H ;
Zhang, JG ;
Hanninen, MS ;
Hochrein, H ;
Chionh, F ;
Shipham, KA ;
Emery, B ;
Turnley, AM ;
Petratos, S ;
Ernst, M ;
Bartlett, PF ;
Kilpatrick, TJ .
NATURE MEDICINE, 2002, 8 (06) :613-619
[7]   Sensorimotor gating in boys with Tourette's syndrome and ADHD: Preliminary results [J].
Castellanos, FX ;
Fine, EJ ;
Kaysen, D ;
Marsh, WL ;
Rapoport, JL ;
Hallett, M .
BIOLOGICAL PSYCHIATRY, 1996, 39 (01) :33-41
[8]   Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation [J].
Chesnokova, V ;
Melmed, S .
ENDOCRINOLOGY, 2000, 141 (11) :4032-4040
[9]   A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: Absence of significant astrocytosis [J].
Damadzic, R ;
Bigelow, LB ;
Krimer, LS ;
Goldenson, DA ;
Saunders, RC ;
Kleinman, JE ;
Herman, MM .
BRAIN RESEARCH BULLETIN, 2001, 55 (05) :611-618
[10]   THE NEUROPSYCHIATRIC EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER-CELLS [J].
DENICOFF, KD ;
RUBINOW, DR ;
PAPA, MZ ;
SIMPSON, C ;
SEIPP, CA ;
LOTZE, MT ;
CHANG, AE ;
ROSENSTEIN, D ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (03) :293-300